Phathom Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PHAT and other ETFs, options, and stocks.About PHAT
Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.
PHAT Key Statistics
Stock Snapshot
The current Phathom Pharmaceuticals(PHAT) stock price is $12.05, with a market capitalization of 941.1M. The stock trades at a price-to-earnings (P/E) ratio of -3.15.
As of 2026-02-13, Phathom Pharmaceuticals(PHAT) stock has fluctuated between $11.80 and $12.40. The current price stands at $12.05, placing the stock +2.1% above today's low and -2.8% off the high.
The Phathom Pharmaceuticals(PHAT)'s current trading volume is 12.56K, compared to an average daily volume of 822.74K.
In the last year, Phathom Pharmaceuticals(PHAT) shares hit a 52-week high of $18.31 and a 52-week low of $2.21.
In the last year, Phathom Pharmaceuticals(PHAT) shares hit a 52-week high of $18.31 and a 52-week low of $2.21.
Analyst ratings
82%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.